Literature DB >> 31081075

LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.

Y-L Zhao1, Y-M Huang.   

Abstract

OBJECTIVE: This study aims to investigate whether small nucleolar RNA host gene 14 (SNHG14) is involved in the development of ovarian cancer through affecting cell proliferation and cell cycle progression by regulating microRNA-125a-5p. PATIENTS AND METHODS: We detected the mRNA expressions of SNHG14 and microRNA-125a-5p by quantitative Polymerase Chain Reaction (qPCR) in ovarian cancer tissues and normal ovarian tissues. Their expression levels in ovarian cancer cell lines were examined as well. Meanwhile, the regulatory effects of SNHG14 and microRNA-125a-5p on cell proliferation and cell cycle were detected by Cell Counting Kit-8 (CCK-8) and flow cytometry, respectively. The binding relationship between microRNA-125a-5p and SNHG14 was examined by the Luciferase reporter gene assay. It was further confirmed by recovery experiments whether SHHG14 can affect the proliferation and cycle of ovarian cancer cells by regulating microRNA-125a-5p.
RESULTS: SNHG14 was highly expressed in ovarian cancer tissues and cell lines relative to controls. The survival curve analysis showed that the AUC was 0.8681 and Cutoff value was 2.33. The five-year survival rate of the high SNHG14 expression group was markedly lower than that of the low SNHG14 expression group. In addition, we found that SNHG14 could accelerate cell proliferation and cell cycle progression of ovarian cancer cells. Dual-Luciferase reporter gene experiments indicated that SNHG14 could bind to microRNA-125a-5p, which was lowly expressed in ovarian cancer patients. However, the overexpression of microRNA-125a-5p reversed the promotive effect of SNHG14 on the proliferation and cell cycle of ovarian cancer cells. Dual-Luciferase reporter gene assay also indicated that DHX33 was a target gene of microRNA-125a-5p. The overexpression of DHX33 could attenuate the inhibitory effect of microRNA-125a-5p on cell proliferation and cell cycle in SKOV3 and OVCAR3 cells.
CONCLUSIONS: High expression of SNHG14 can promote the ovarian cancer cell proliferation and accelerate the cell cycle by sponging microRNA-125a-5p to regulate DHX33 expression.

Entities:  

Year:  2019        PMID: 31081075     DOI: 10.26355/eurrev_201904_17683

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

Review 1.  The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.

Authors:  Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Aida Barreiro-Alonso; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; María Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2020-04-21       Impact factor: 6.639

2.  Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p/ESM1 axis.

Authors:  Rui Feng; Zhongxing Li; Xing Wang; Guangcheng Ge; Yuejun Jia; Dan Wu; Yali Ji; Chenghao Wang
Journal:  Cancer Cell Int       Date:  2021-01-22       Impact factor: 5.722

3.  Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.

Authors:  Xiaowen Sun; Hui Shen; Shubin Liu; Jing Gao; Shuyan Zhang
Journal:  Int J Mol Med       Date:  2020-03-20       Impact factor: 4.101

4.  LncRNA SNHG14 contributes to the progression of NSCLC through miR-206/G6PD pathway.

Authors:  Lin Zhao; Xiaodong Zhang; Yantong Shi; Tianlu Teng
Journal:  Thorac Cancer       Date:  2020-03-09       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.